After a weak first half, the drug and biotech sector has recovered in the past 2-3 months with large drugmakers like Pfizer, ...

With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...

Healthcare and biotech stocks offer tempting valuations following years in the doldrums ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

2025 has been the best year for biotechs being acquired by pharma companies since 2019, with nearly $240 billion worth of ...

Shares in the industry offer attractive opportunities even after the sector’s big run this year, according to Jefferies.